At the UBS Global Healthcare Conference 2025 , over three days industry leaders and investors gathered to examine the forces shaping the future of healthcare – from scalable innovation and value-based care models to the pricing dynamics of high-impact drugs and the commercial rise of GLP-1s. ​

Keynotes and panel discussions spotlighted biotech advances in RNA editing and radiological techniques, alongside evolving trends in healthcare services and managed care, offering a strategic lens on where capital, leadership, and disruption converge.

Conference highlights

In partnership with the Financial Times

The new blueprint for biotech

Will US drug pricing policy slow the GLP-1 boom?

Healthcare rewired: what reforms mean for US markets​